Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
F1000Research|November 4, 2017
Recent advances in the management of pediatric acute lymphoblastic leukemiaJan Starý, Ondřej HrušákVnitrni Lekarstvi|September 9, 2018
Hematopoietic stem cell transplantation for non-malignant hematological disordersRenata Formánková, Jan StarýF1000Research|October 23, 2018
New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemiaJan Starý, Jan Zuna, Marketa ZaliovaPediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 13, 2003
Development of common variable immunodeficiency in a patient with Evans syndrome treated by autologous stem cell transplantationJan Starý, Petr Sedlácek, Sárka Vodvárková, et al.Leukemia & Lymphoma|October 27, 2006
Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosineHubert Mottl, Jan Starý, Markéta Chánová, et al.Current Opinion in Oncology|February 6, 2013
Optimizing asparaginase therapy for acute lymphoblastic leukemiaCarmelo Rizzari, Valentino Conter, Jan Starý, et al.Leukemia & Lymphoma|December 17, 2002
Microsatellite instability in hematological malignanciesLenka Krsková-Honzátková, Jaroslav Cermák, Jana Sajdová, et al.Ceskoslovenska Patologie|March 15, 2014
Expression of the active caspase-3 in children and adolescents with classical Hodgkin lymphomaMichaela Cepelová, Kateřina Kamarádová, Edita Kabíčková, et al.Cancer Immunology, Immunotherapy : CII|March 21, 2002
Generation of functional dendritic cells for potential use in the treatment of acute lymphoblastic leukemiaDagmar Pospísilová, Jirina Borovicková, Andrea Poloucková, et al.Leukemia & Lymphoma|July 16, 2009
Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-KIT, FLT3, and JAK2 mutations on clinical outcomeJana Marková, Jana Marková, Zuzana Trnková, et al.Pageof 5